January 24, 2019 / 12:28 PM / 6 months ago

India's Biocon quarterly profit more than doubles, beats estimate

Jan 24 (Reuters) - Indian biotechnology firm Biocon Ltd’s quarterly profit more than doubled, handily beating analysts’ estimates, largely driven by strong performance of its biologics businesses.

Profit rose to 2.17 billion rupees ($30.54 million) in the third quarter ended Dec. 31, compared with a profit of 919 million rupees a year earlier, the company said here on Thursday.

Nine analysts on an average had expected a profit of 1.76 billion rupees, according to Refinitiv Eikon data.

Revenue from operations grew 45.6 percent to 154.08 billion rupees, while revenue from its biologics segment more than doubled. ($1 = 71.0580 Indian rupees) (Reporting by Krishna V Kurup in Bengaluru; Editing by Subhranshu Sahu)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below